What is the validity of antitetanus (antitetanus) serum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Validity of Antitetanus Serum

Antitetanus serum (tetanus immunoglobulin) provides short-term protection against tetanus for approximately 4 weeks, while animal-derived antitetanus serum is valid for only 7-10 days. 1

Duration of Protection

Tetanus immunoglobulin provides passive immunity with the following characteristics:

  • Human tetanus immunoglobulin (TIG):

    • Provides protection for approximately 4 weeks 1
    • Standard dose is 250 units intramuscularly at a site different from toxoid injection 2
    • Causes fewer adverse reactions compared to animal-derived products 1
  • Animal-derived antitetanus serum:

    • Provides protection for only 7-10 days 1
    • Associated with more undesirable reactions 1
    • Historical products (such as those from WWI) have been shown to lose their neutralization capacity over time 3

Efficacy and Limitations

The efficacy of tetanus immunoglobulin depends on several factors:

  • Tetanus immunoglobulin works by neutralizing circulating tetanus toxin that has not yet bound to nerve tissue 2
  • It cannot reverse toxin already bound to nerve endings 2
  • A study examining a century-old vial of tetanus antiserum from World War I found that while IgG proteins were still present, they had lost their functional neutralizing capacity 3
  • Even with seemingly protective antibody levels, rare cases of severe tetanus can occur, as documented in a case series of three immunized patients who developed grade III tetanus despite having high anti-tetanus antibody titers 4

Clinical Applications

For optimal tetanus prophylaxis in wound management:

  1. For clean, minor wounds:

    • TIG is not indicated if the patient has received ≥3 doses of tetanus toxoid 5, 2
    • Tetanus toxoid booster is indicated if >10 years since last dose 5, 2
  2. For tetanus-prone wounds (contaminated, puncture, or with devitalized tissue):

    • TIG is indicated for patients with unknown or <3 doses of tetanus toxoid 2
    • Tetanus toxoid booster is indicated if >5 years since last dose 5, 2
  3. When both TIG and tetanus toxoid are indicated:

    • Administer simultaneously at different sites 6
    • This approach provides faster protection than either giving the first vaccination one month after the serum injection or mixing them together 6

Active vs. Passive Immunization

While antitetanus serum provides immediate but temporary protection, active immunization with tetanus toxoid is superior for long-term protection:

  • After a primary immunization series with 3 doses of tetanus toxoid, virtually all infants and adults develop protective tetanus antitoxin titers >0.1 IU/mL 5
  • A primary series provides protection for approximately 3-5 years 5
  • Additional booster doses heighten the immune response and prolong protection, with booster doses at age 4-8 years and during adolescence providing protection for 20-30 years 5
  • For adults, Tdap is preferred over Td for those who have not previously received Tdap 5

Common Pitfalls

  • Relying solely on antitetanus serum without initiating active immunization in unvaccinated individuals 1, 6
  • Assuming complete protection based on antibody titers alone, as rare cases of tetanus can occur despite seemingly protective levels 4
  • Neglecting proper wound cleaning and debridement, which are as important as immunization in preventing tetanus 2
  • Using outdated or improperly stored antitetanus serum products, which may have lost their neutralizing capacity 3

Remember that the minimum level of circulating antitetanus antibodies associated with protection is 0.01 IU/mL by in vivo toxin neutralization assay, while levels ≥0.1 IU/mL as measured by ELISA are generally considered protective 5, 7.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.